Rituximab in Auto-Immune Hemolytic Anemia
Clinical trial NCT01181154 · COMPLETED
Trial details
- NCT number
- NCT01181154
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-03
- Primary completion
- 2015-01-08
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.